Abstract
Sarcomatoid renal adenocarcinomas are rare, invariably fatal tumors. There is only one report of treatment of this tumor with chemotherapy. We report a case of an advanced sarcomatoid renal adenocarcinoma treated with chemo‐immunotherapy consisting of cyclophosphamide, vincristine, Adriamycin (doxorubicin), DTIC, BCG, and sarcoma viral oncolysate. The patient had an objective response with a marked reduction in the size of the tumor mass. The residual tumor was removed surgically, and the patient remains in complete remission two years after the diagnosis was made.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 9-13 |
| Number of pages | 5 |
| Journal | Medical and Pediatric Oncology |
| Volume | 5 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1978 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- carcinosarcoma
- chemoimmunotherapy
- sarcomatoid renal adenocarcinoma
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Chemoimmunotherapy of sarcomatoid renal cell carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS